Characterization of Single Nucleotide Variants of OPN3 Gene in Melanocytic Nevi and Melanoma

• Main Authors: Wei Zhang, Jianglong Feng, Wen Zeng, Zhixu Zhou, Yu Wang, Hongguang Lu
• Format: Article
• Language: English
• Published: Elsevier 2021-03-01
• Series: JID Innovations
• Online Access: http://www.sciencedirect.com/science/article/pii/S2667026721000060

In this study, we examined single nucleotide variants (SNVs) of the OPN3 gene in malignant melanoma and melanocytic nevi. A total of 20 variants of SNVs were detected. Of these variants, five nonsynonymous mutations of OPN3 were identified, including c.T152C, c.T401C, c.G547A, c.G768A, and c.G992A. Three prediction tools, MutationTaster2, Polymorphism Phenotyping version 2, and PROVEAN (Protein Variation Effect Analyzer), which predict possible impact of an amino acid substitution, suggested that the mutations could be deleterious. Nine SNVs occurred in 3′ untranslated regions, whereas two were observed in 5′ untranslated regions. In all cases, four intronic variants were identified. In addition, we identified nine 3′ untranslated region SNVs in OPN3; one of them (OPN3[NM_014322:c.∗83C>T]) is predicted to disrupt a conserved microRNA (has-miR-376c-3p) target site, located in position 86–93 of OPN3 3′ untranslated region. Our findings suggest that there is a strong possibility that OPN3 SNVs play a role in the pathogenesis of melanocytic tumors via prediction of functional phenotype.